Backtesting that
doesn't lie to you.
The Deflated Sharpe Ratio. Walk-forward decay. CPCV. The statistical machinery quant funds use to know whether a backtest is real — now in a tool built for serious retail traders who are tired of being misled by their own Sharpe ratios.
The problem with most backtests
You pick indicators, tune parameters, see an in-sample Sharpe of 2.4, and conclude you have a strategy. You don't. You have a curve-fit. The Sharpe ratio rewards you for looking at data until something works.
Institutional quant research corrects for this. Retail tooling pretends the problem doesn't exist. Kestrel Signal closes that gap — and shows you the validity metrics whether you want to see them or not.
What makes this different
Built around the metrics that matter
Who this is for
You write Python. You know the Sharpe ratio is misleading but you've been using it anyway because everything else does too. You trade your own capital, run real tests, and you're frustrated that every backtesting tool optimistically hands you a Sharpe of 2.1 and calls it a day.
Kestrel Signal is built for you — not for beginners who want signals, not for funds who have their own infra. For the serious retail quant who wants to know if their strategy is real before they trade it.
Pricing
Start free. Upgrade when you need more.
All prices SGD · Annual billing saves ~20% · Lab includes 14-day trial · DSR free on all tiers
Know if your strategy is real.
Free tier includes DSR and validity metrics on every backtest. No credit card. No waitlist.
Start free